Dr. Subhash C. Proothi, MD

Dr. Proothi practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Proothi's NPI, 1376537621, was assigned on September 1, 2005. Dr. Proothi holds Pennsylvania license MD022180E.

Dr. Proothi's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Proothi's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Proothi is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Proothi to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Proothi practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Proothi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Proothi is licensed in Pennsylvania.

CMS data shows 2,407 Medicare services from Dr. Proothi across 11 procedure codes in 2024, for 611 Medicare patients. Medicare paid $148,778 for them.

CMS counts 611 Medicare patients who saw Dr. Proothi in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Proothi's median patient age at 75, with 63% women.

In 2024, Dr. Proothi wrote 1,778 Medicare Part D claims for 296 patients. 65% of them were for generic drugs. CMS names the drug for 1,605 of them, across 43 drugs with 11 or more claims each, at $5,965,533 in total drug cost. In 2023, CMS named 1,724 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Proothi for performance year 2024, reported through an alternative payment model (APM). Dr. Proothi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Proothi as offering telehealth.

CMS Open Payments shows 535 general payments to Dr. Proothi from 46 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Merck Sharp & Dohme Corporation paid the most, $30,008.